December 2nd, 2011 by admin in Announcements, Health Tips
No Comments »
Getting a flu vaccine is on many “to do” lists in the fall, but for those who still haven’t checked it off their list, it’s not too late to get vaccinated. Many people don’t realize that flu activity usually peaks in the United States in January or February, and flu viruses can circulate as late as May. As long as there’s flu around, it isn’t too late to get vaccinated.
Getting a yearly flu vaccine is the first and most important step in protecting against the flu, and CDC recommends influenza vaccination for everyone age 6 months and older. We urge you and all health care professionals to get vaccinated yourselves and offer flu vaccine at every opportunity to every patient—except infants younger than 6 months and the very few people for whom flu vaccination is contraindicated.
Studies show that your recommendation makes the difference in your patients’ decision to get a flu vaccine. You should continue to emphasize the importance of flu vaccination for your patients. And, if you don’t already do so, consider offering flu vaccines to patients in your own practice, even if yours is a sub-specialty practice and you don’t see yourself as a vaccine provider. Even if you don’t offer flu vaccines, you can still recommend and emphasize the importance of flu vaccination as a way to keep your patients—and their families—protected throughout the season.
As promising as it is sounds that flu vaccination rates are increasing among children and healthcare personnel, Read more »
*This blog post was originally published at Safe Healthcare*
December 1st, 2011 by MuinKhouryMDPhD in Opinion, Research
No Comments »
In June 2011, the CDC Office of Public Health Genomics launched a community wide consultation process to develop priorities for the field of public health genomics in the next 5 years. This process was initiated as part of strategic visioning for integrating the emerging tools of genomics into practice and assuring the success of these new tools in improving population health. The process was conducted at a time of a widening gap between the rapid scientific advances in genomics and their impact on improving population health. The University of Michigan Center for Public Health and Community Genomics and Genetic Alliance spearheaded an effort to seek, collate and synthesize advice and recommendations from numerous stakeholders and constituents. The effort culminated in a workshop conducted on September 14, 2011 in Bethesda, Maryland. The results of the consultation, discussions and deliberations are summarized in a report published by the University of Michigan. Highlights of the recommendations are summarized here but readers should consult the full report. Some of the recommendations include:
To improve public health genomics education: Read more »
*This blog post was originally published at Genomics and Health Impact Blog*
November 24th, 2011 by Toni Brayer, M.D. in Research
No Comments »
I live on the West Coast, where it is rare to see a smoker. Because it is not socially accepted, smokers are not out in the open. They lurk behind buildings to take a smoke break at work and I don’t even own an ashtray for friends because none of my friends smoke. But San Francisco isn’t the rest of America. In 2010 there were 45.5 million Americans who smoke, with men smoking more than women. Tobacco remains the single largest preventable cause of death and disease in the United States. Each year approximately 433,000 people die of smoking-related illness.
Here are some more stats on American adult smokers. The highest prevalence is American Indians/Alaska Natives (31.4%) followed by whites (21%). Smoking incidence decreases with increasing education and improved economics. By region, the Midwest has the most smokers in Oklahoma, Arkansas, Mississippi, Louisiana, Kentucky, Ohio and West Virginia (22-27%). That is huge.
California and Utah have the lowest percentage of adult smokers at Read more »
*This blog post was originally published at EverythingHealth*
November 13th, 2011 by Dr. Val Jones in News, Opinion, Quackery Exposed
12 Comments »
I’ve been following the recent Delta airlines flu vaccine kerfuffle with interest and now amazement. After running in-flight infomercials by a notorious anti-vaccine group (NVIC), the American Academy of Pediatrics alerted Delta to the faux pas with a letter from president Robert W. Block, M.D. I had assumed that Delta would be grateful for the head’s up, and would immediately remove the infomercials. Instead, they chose to ignore the letter, denying that they saw any harm in associating themselves with anti-vaccine activists. Despite the warning, they will continue to run the ads through the month of November.
Every year the influenza virus kills as many as 49,000 Americans and 500,000 individuals world-wide. According to the CDC, the best defense against these often preventable deaths is the influenza vaccine. Since viral spread is especially likely in closed quarters where air from infected individuals is recirculated (such as in an airplane) it is critical for extra precautions to be taken before and during air travel. In addition to yearly flu vaccination, the use of alcohol-based hand wipes, regular hand washing, covering one’s mouth during coughing, are recommended. Since the flu virus can live in droplets outside the body for up to 48 hours, door knobs, seat covers and tray tables can spread the virus from passengers on previous flights.
I don’t understand why Delta, Read more »
November 11th, 2011 by MelissaSchaeferMD in News
No Comments »
Antimicrobial resistance is a world-wide problem and increases the difficulty a variety of infections. In the United States, the major threat that is faced each day by millions of Americans every year is posed by bacteria that are resistant to antibiotics. Studies to obtain precise estimates for all types of resistant infections is ongoing, but we do know that every year, almost 90,000 people become ill with infections caused by one of these resistant bacteria—methicillin-resistant Staphylococcus aureus or MRSA. Of these people, over 15,000 die.
Tremendously effective strategies have been developed to prevent infections, especially those likely to be caused by resistant bacteria. Readers of this blog are very familiar with the wide range of evidence-based, proven-effective interventions that reduce the incidence of infections and prevent the transmission of dangerous pathogens between people, especially hospitalized patients who are most at risk.
But a critical strategy for preventing the development of drug resistance in bacteria is to use antibiotics carefully and judiciously. Scientists have known for 70 years, Read more »
*This blog post was originally published at Safe Healthcare*
